Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-23-006529

Chief Business Officer acquired 107,202 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Martin Michael Robert Chief Business Officer 2023-03-02 Grant or award +107,202 259,162 D
Loading xslF345X03/wf-form4_167813811794255.xml…